Title Page / Table of Contents.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 57, doi. 10.1159/000323649
- Publication type:
- Article
Works matching IS 1424862X AND DT 2011 AND VI 18 AND IP 2
Results: 9
1
2
Editorial Note.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 61, doi. 10.1159/000323648
- By:
- Publication type:
- Article
3
Cell Adhesion Molecules and Their Involvement in Autism Spectrum Disorder.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 62, doi. 10.1159/000322543
- By:
- Publication type:
- Article
4
The Role of Calcium-Dependent Gene Expression in Autism Spectrum Disorders: Lessons from MeCP2, Ube3a and Beyond.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 72, doi. 10.1159/000320970
- By:
- Publication type:
- Article
5
The Contribution of Oxytocin and Vasopressin to Mammalian Social Behavior: Potential Role in Autism Spectrum Disorder.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 82, doi. 10.1159/000321035
- By:
- Publication type:
- Article
6
The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 98, doi. 10.1159/000323189
- By:
- Publication type:
- Article
7
Maternal Immune Activation and Autism Spectrum Disorder: Interleukin-6 Signaling as a Key Mechanistic Pathway.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 113, doi. 10.1159/000319828
- By:
- Publication type:
- Article
8
The Timing and Specificity of Prenatal Immune Risk Factors for Autism Modeled in the Mouse and Relevance to Schizophrenia.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 129, doi. 10.1159/000321080
- By:
- Publication type:
- Article
9
Author and Subject Index Vol. 18, No. 2, 2010.
- Published in:
- NeuroSignals (Karger AG), 2011, v. 18, n. 2, p. 140, doi. 10.1159/000323650
- Publication type:
- Article